Month: July 2019

Pauline M. Maki, PhD In clinical practice and research studies, midlife women report a worsening of mood as they transition through the menopause. The risk of major depressive disorder (MDD) also increases as women transition through the menopause, though this...
  • July 23, 2019
Read More
Pauline M. Maki, PhD There is considerable debate about the effects of menopausal hormone therapy (MHT) on cognition and risk for Alzheimer’s disease (AD). Small randomized trials show benefits of estrogen therapy (ET) on memory performance following oophorectomy. In a...
  • July 23, 2019
Read More
Andrew Grey1 1University of Auckland Calcium and vitamin D were recommended for management of fracture risk for 30 years, on the basis of plausibility, studies with surrogate outcomes and a clinical trial conducted in a frail institutionalized vitamin D-deficient population....
  • July 18, 2019
Read More
Associate Professor Kirsten Black Knowing how to identify and investigate abnormal bleeding in women during the menopausal transition, the menopause, and while on MHT can be challenging. This talk will address common bleeding presentations in the perimenopause and discuss when...
  • July 18, 2019
Read More
Rethink MHT: Introducing a New Transdermal Estradiol Gel 07:00 Room Opens – Breakfast 07:10 Topic 1: Body Identical MHT – Replacing the Body’s Hormones with the Body’s Hormones Speaker 1: Dr Elizabeth Farrell AM MBBS FRCOG FRANZCOG 07:30 Topic 2:...
  • July 17, 2019
Read More
Critical Consultations in Osteoporosis during menopause Session chair: Dr Jane Elliott, General Practitioner, South Australia Presenter: Dr Esther Briganti, Endocrinologist, Melbourne This case-study based presentation provides practical tips and information for discussing bone health with patients during menopause. The focus...
  • July 17, 2019
Read More
Dr Jocelyn Lippey Ductal carcinoma in situ (DCIS) accounts for approximately 20% of all new “breast cancer” diagnoses in Australia each year. Despite the word carcinoma within the name it holds no malignant potential and the diagnosis itself has no...
  • July 8, 2019
Read More
Dr Kelly Teagle1 1Wellfemme, Canberra, Australia Current evidence suggests that up to 385,000 Australian women currently experience moderate to severe hot flushes, yet only a small percentage are using effective treatments. Women in rural and remote areas have the lowest...
  • July 2, 2019
Read More
Dr Neisha Wratten1 1Dr Neisha K. Wratten, Marden, Australia In 2017, an Australian series of 102 women with symptoms of GSM treated by fractional CO2 laser was published. 84% of women experienced improvement in their symptoms after 12 -24 months...
  • July 2, 2019
Read More
Dr Rukshini Puvanendran1, Ms Mei Tuan Chua1 1KKH, Singhealth, Singapore Background: Atypical femoral fractures (AFF) are an uncommon side-effect of anti-osteoporotic treatment with bisphosphonates (BP) and Denosumab. Objectives: We report a case of incomplete AFF after bisphosphonate use. Methods: 68-year-old...
  • July 2, 2019
Read More